Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Dutasteride may become the top choice for treating hair loss.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

A new compound effectively inhibits human 5α-reductase 1.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

A new method to make finasteride for hair loss treatment was developed.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

New progesterone-based compounds can block male hormones.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

A new compound that could treat various androgen-related conditions was created and analyzed.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Neogynon effectively prevents pregnancy but may cause side effects like headaches and menstrual changes.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

The formulation with oleic acid may be better for treating male pattern baldness.

Compound 15a was effective in inhibiting 5α-reductase.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.